Queen Mary University of London Launches Spinout Procyon Diagnostics to Provide Early Cancer Tests
October 23, 2025
October 23, 2025
LONDON, England, Oct. 23 -- Queen Mary University of London issued the following news:
* * *
Queen Mary University of London launches new spinout Procyon Diagnostics to provide early cancer tests
Procyon is a new cancer diagnostics spinout from Queen Mary University of London which has just completed an oversubscribed pre-seed round. The new company aims to become a leading provider of biomarker technologies for early cancer detection.
*
. . .
* * *
Queen Mary University of London launches new spinout Procyon Diagnostics to provide early cancer tests
Procyon is a new cancer diagnostics spinout from Queen Mary University of London which has just completed an oversubscribed pre-seed round. The new company aims to become a leading provider of biomarker technologies for early cancer detection.
*
. . .
